J Herbmed Pharmacol. 2019;8(4): 261-268.
doi: 10.15171/jhp.2019.38
  Abstract View: 654
  PDF Download: 538


Molecular targets of honey bee’s products in cancer prevention and treatment

Ablassé Rouamba 1* ORCID logo, Moussa Compaoré 1 ORCID logo, Martin Kiendrebeogo 1 ORCID logo

1 Laboratory of Applied Biochemistry and Chemistry (LABIOCA), UFR-SVT, University Ouaga 1 Pr Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso


Chemotherapy and radiotherapy are currently the main treatments for cancer but their toxicities on the surrounding normal cells limit their use in cancer therapy. Moreover, many cancers have developed some resistance to the available anticancer chemicals and put in failure the chemotherapy currently used in the cancer treatment. This failure of the targeted monotherapy resulting from bypass mechanisms has obligated researchers to use agents that interfere with multiple cell-signaling pathways. Recently, researches focused on the use of natural products which can target cancer promoting factors genes expression. Of these natural products, honey has been extensively studied. The pharmacological properties of honey include antioxidant, anti-inflammatory, antibacterial, immunomodulatory, estrogenic and anti-cancer effects. The honey bee’s products are potent sources of nutritional components including sugar, amino-acids, water and minerals. Furthermore honey contains chemopreventive compounds such as flavonoids, phenol acids, tannins, vitamins that may interfere with multiple cell’s pathways and hereby reduce the incidence of many types of cancers. However, the molecular mechanisms of honey bee’s products in cancer prevention and treatment are less known. This review highlights the molecular mechanism of honey bioactive compounds in cancer prevention and treatment.
Keywords: Cancer, Cell signaling pathways, Chemotherapy, Chemopreventive compounds, Honey

Implication for health policy/practice/research/medical education:

Honey bee’s products are potent anticancer agents. Its anticancer mechanisms include oncogenic gene inhibition, pro-apoptotic factor activation, antioxidant and DNA repair activities. Understanding the molecular mechanism of honey bee’s products can promote new strategy to develop effective anticancer drugs.

Please cite this paper as: Rouamba A, Compaoré M, Kiendrebeogo M. Molecular targets of honey bee’s products in cancer prevention and treatment. J Herbmed Pharmacol. 2019;8(4):261-268. doi: 10.15171/jhp.2019.38.

First Name
Last Name
Email Address
Security code

Abstract View: 654

Your browser does not support the canvas element.

PDF Download: 538

Your browser does not support the canvas element.

Submitted: 12 Sep 2018
Accepted: 08 Mar 2019
ePublished: 01 Aug 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)